Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
Clinical Lung Cancer|April 9, 2018
A Decade of Never-smokers Among Lung Cancer Patients-Increasing Trend and Improved SurvivalChee-Keong Toh, Whee-Sze Ong, Wan-Teck Lim, et al.BMC Cancer|December 26, 2018
Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.BMC Cancer|December 5, 2018
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2016
EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC PatientsNatalia Sutiman, Shao Weng Tan, Eng Huat Tan, et al.Radiology|June 16, 2012
Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxiaHenry C Mandeville, Quan Sing Ng, Frances M Daley, et al.European Urology|July 15, 2014
A multigene assay identifying distinct prognostic subtypes of clear cell renal cell carcinoma with differential response to tyrosine kinase inhibitionYukti Choudhury, Xiaona Wei, Ying-Hsia Chu, et al.Pharmacogenetics and Genomics|January 7, 2017
Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patientsCharlie Marvalim, Jing Xiang Gimson Wong, Natalia Sutiman, et al.Clinical Genitourinary Cancer|December 27, 2014
Efficacy and Safety of an Attenuated-Dose Sunitinib Regimen in Metastatic Renal Cell Carcinoma: Results From a Prospective Registry in SingaporeHui Shan Tan, Huihua Li, Yu Wen Hong, et al.Plos One|August 6, 2015
Association of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell CarcinomaYing-Hsia Chu, Huihua Li, Hui Shan Tan, et al.Asia-Pacific Journal of Clinical Oncology|November 13, 2019
Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experienceJohan Chan, Shi Yin Yap, Yian Ching Fong, et al.Pageof 7